ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cold and Flu Drugs Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-23A9493
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Cold and Flu Drugs Market Insights Forecast to 2028
BUY CHAPTERS

Global Cold and Flu Drugs Market Research Report 2025

Code: QYRE-Auto-23A9493
Report
July 2025
Pages:75
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Reckitt Benckiser Group
Johnson & Johnson
GlaxoSmithKline PLC
Novartis
Bayer
Astrazeneca plc
Sun Pharmaceutical Industries
Pfizer Inc
Prestige Brands Holdings
Procter Gamble
Johnson & Johnson

Cold and Flu Drugs Market Size

The global market for Cold and Flu Drugs was valued at US$ 44520 million in the year 2024 and is projected to reach a revised size of US$ 64850 million by 2031, growing at a CAGR of 5.6% during the forecast period.

Cold and Flu Drugs Market

Cold and Flu Drugs Market

Cold medicines are medications used by people with the common cold, cough, or related conditions. There is, however, no good evidence that cough medications reduce coughing.
The Cough and Cold Remedies Market is driven by the recurring nature of respiratory ailments and seasonal illnesses, such as coughs and colds, which create a consistent demand for over-the-counter remedies. Cough and cold remedies, including cough syrups, decongestants, and throat lozenges, provide individuals with relief from common symptoms and discomfort associated with these ailments. As consumers prioritize self-care and symptom management, the market for these remedies continues to expand. The advent of innovative formulations and delivery methods further fuels market growth. However, a significant challenge for this market is the need to address regulatory and safety concerns surrounding certain ingredients, ensuring that remedies are effective and safe for users. Overcoming the evolving landscape of cold and flu viruses and the need to tailor products to address specific symptoms pose ongoing challenges. Additionally, the market faces competition from alternative therapies, natural remedies, and preventive measures. Striking a balance between providing accessible and reliable remedies for symptom relief while navigating evolving consumer preferences and safety considerations is crucial for the continued growth of the Cough and Cold Remedies Market.
This report aims to provide a comprehensive presentation of the global market for Cold and Flu Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cold and Flu Drugs.
The Cold and Flu Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cold and Flu Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cold and Flu Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Cold and Flu Drugs Market Report

Report Metric Details
Report Name Cold and Flu Drugs Market
Accounted market size in year US$ 44520 million
Forecasted market size in 2031 US$ 64850 million
CAGR 5.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Reckitt Benckiser Group, Johnson & Johnson, GlaxoSmithKline, Novartis, Bayer, AstraZeneca, Sun Pharmaceutical Industries, Pfizer, Prestige Brands Holdings, Procter & Gamble
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cold and Flu Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Cold and Flu Drugs Market growing?

Ans: The Cold and Flu Drugs Market witnessing a CAGR of 5.6% during the forecast period 2025-2031.

What is the Cold and Flu Drugs Market size in 2031?

Ans: The Cold and Flu Drugs Market size in 2031 will be US$ 64850 million.

Who are the main players in the Cold and Flu Drugs Market report?

Ans: The main players in the Cold and Flu Drugs Market are Reckitt Benckiser Group, Johnson & Johnson, GlaxoSmithKline, Novartis, Bayer, AstraZeneca, Sun Pharmaceutical Industries, Pfizer, Prestige Brands Holdings, Procter & Gamble

What are the Application segmentation covered in the Cold and Flu Drugs Market report?

Ans: The Applications covered in the Cold and Flu Drugs Market report are OTC, Rx

What are the Type segmentation covered in the Cold and Flu Drugs Market report?

Ans: The Types covered in the Cold and Flu Drugs Market report are Antihistamines, Expectorants, Bronchodilators, Decongestants, Antibiotics, Others

Recommended Reports

Respiratory Disease Drugs

Cold & Flu Vaccines

OTC & Sore Throat Remedies

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cold and Flu Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antihistamines
1.2.3 Expectorants
1.2.4 Bronchodilators
1.2.5 Decongestants
1.2.6 Antibiotics
1.2.7 Others
1.3 Market by Application
1.3.1 Global Cold and Flu Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 OTC
1.3.3 Rx
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cold and Flu Drugs Market Perspective (2020-2031)
2.2 Global Cold and Flu Drugs Growth Trends by Region
2.2.1 Global Cold and Flu Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cold and Flu Drugs Historic Market Size by Region (2020-2025)
2.2.3 Cold and Flu Drugs Forecasted Market Size by Region (2026-2031)
2.3 Cold and Flu Drugs Market Dynamics
2.3.1 Cold and Flu Drugs Industry Trends
2.3.2 Cold and Flu Drugs Market Drivers
2.3.3 Cold and Flu Drugs Market Challenges
2.3.4 Cold and Flu Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cold and Flu Drugs Players by Revenue
3.1.1 Global Top Cold and Flu Drugs Players by Revenue (2020-2025)
3.1.2 Global Cold and Flu Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Cold and Flu Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cold and Flu Drugs Revenue
3.4 Global Cold and Flu Drugs Market Concentration Ratio
3.4.1 Global Cold and Flu Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cold and Flu Drugs Revenue in 2024
3.5 Global Key Players of Cold and Flu Drugs Head office and Area Served
3.6 Global Key Players of Cold and Flu Drugs, Product and Application
3.7 Global Key Players of Cold and Flu Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cold and Flu Drugs Breakdown Data by Type
4.1 Global Cold and Flu Drugs Historic Market Size by Type (2020-2025)
4.2 Global Cold and Flu Drugs Forecasted Market Size by Type (2026-2031)
5 Cold and Flu Drugs Breakdown Data by Application
5.1 Global Cold and Flu Drugs Historic Market Size by Application (2020-2025)
5.2 Global Cold and Flu Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cold and Flu Drugs Market Size (2020-2031)
6.2 North America Cold and Flu Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cold and Flu Drugs Market Size by Country (2020-2025)
6.4 North America Cold and Flu Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cold and Flu Drugs Market Size (2020-2031)
7.2 Europe Cold and Flu Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cold and Flu Drugs Market Size by Country (2020-2025)
7.4 Europe Cold and Flu Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cold and Flu Drugs Market Size (2020-2031)
8.2 Asia-Pacific Cold and Flu Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cold and Flu Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Cold and Flu Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cold and Flu Drugs Market Size (2020-2031)
9.2 Latin America Cold and Flu Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cold and Flu Drugs Market Size by Country (2020-2025)
9.4 Latin America Cold and Flu Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cold and Flu Drugs Market Size (2020-2031)
10.2 Middle East & Africa Cold and Flu Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cold and Flu Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Cold and Flu Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Reckitt Benckiser Group
11.1.1 Reckitt Benckiser Group Company Details
11.1.2 Reckitt Benckiser Group Business Overview
11.1.3 Reckitt Benckiser Group Cold and Flu Drugs Introduction
11.1.4 Reckitt Benckiser Group Revenue in Cold and Flu Drugs Business (2020-2025)
11.1.5 Reckitt Benckiser Group Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Cold and Flu Drugs Introduction
11.2.4 Johnson & Johnson Revenue in Cold and Flu Drugs Business (2020-2025)
11.2.5 Johnson & Johnson Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Cold and Flu Drugs Introduction
11.3.4 GlaxoSmithKline Revenue in Cold and Flu Drugs Business (2020-2025)
11.3.5 GlaxoSmithKline Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Cold and Flu Drugs Introduction
11.4.4 Novartis Revenue in Cold and Flu Drugs Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer Cold and Flu Drugs Introduction
11.5.4 Bayer Revenue in Cold and Flu Drugs Business (2020-2025)
11.5.5 Bayer Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Cold and Flu Drugs Introduction
11.6.4 AstraZeneca Revenue in Cold and Flu Drugs Business (2020-2025)
11.6.5 AstraZeneca Recent Development
11.7 Sun Pharmaceutical Industries
11.7.1 Sun Pharmaceutical Industries Company Details
11.7.2 Sun Pharmaceutical Industries Business Overview
11.7.3 Sun Pharmaceutical Industries Cold and Flu Drugs Introduction
11.7.4 Sun Pharmaceutical Industries Revenue in Cold and Flu Drugs Business (2020-2025)
11.7.5 Sun Pharmaceutical Industries Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Cold and Flu Drugs Introduction
11.8.4 Pfizer Revenue in Cold and Flu Drugs Business (2020-2025)
11.8.5 Pfizer Recent Development
11.9 Prestige Brands Holdings
11.9.1 Prestige Brands Holdings Company Details
11.9.2 Prestige Brands Holdings Business Overview
11.9.3 Prestige Brands Holdings Cold and Flu Drugs Introduction
11.9.4 Prestige Brands Holdings Revenue in Cold and Flu Drugs Business (2020-2025)
11.9.5 Prestige Brands Holdings Recent Development
11.10 Procter & Gamble
11.10.1 Procter & Gamble Company Details
11.10.2 Procter & Gamble Business Overview
11.10.3 Procter & Gamble Cold and Flu Drugs Introduction
11.10.4 Procter & Gamble Revenue in Cold and Flu Drugs Business (2020-2025)
11.10.5 Procter & Gamble Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Reckitt Benckiser Group
Johnson & Johnson
GlaxoSmithKline PLC
Novartis
Bayer
Astrazeneca plc
Sun Pharmaceutical Industries
Pfizer Inc
Prestige Brands Holdings
Procter Gamble
Johnson & Johnson
List of Tables
 Table 1. Global Cold and Flu Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Antihistamines
 Table 3. Key Players of Expectorants
 Table 4. Key Players of Bronchodilators
 Table 5. Key Players of Decongestants
 Table 6. Key Players of Antibiotics
 Table 7. Key Players of Others
 Table 8. Global Cold and Flu Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Cold and Flu Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Cold and Flu Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 11. Global Cold and Flu Drugs Market Share by Region (2020-2025)
 Table 12. Global Cold and Flu Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 13. Global Cold and Flu Drugs Market Share by Region (2026-2031)
 Table 14. Cold and Flu Drugs Market Trends
 Table 15. Cold and Flu Drugs Market Drivers
 Table 16. Cold and Flu Drugs Market Challenges
 Table 17. Cold and Flu Drugs Market Restraints
 Table 18. Global Cold and Flu Drugs Revenue by Players (2020-2025) & (US$ Million)
 Table 19. Global Cold and Flu Drugs Market Share by Players (2020-2025)
 Table 20. Global Top Cold and Flu Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cold and Flu Drugs as of 2024)
 Table 21. Ranking of Global Top Cold and Flu Drugs Companies by Revenue (US$ Million) in 2024
 Table 22. Global 5 Largest Players Market Share by Cold and Flu Drugs Revenue (CR5 and HHI) & (2020-2025)
 Table 23. Global Key Players of Cold and Flu Drugs, Headquarters and Area Served
 Table 24. Global Key Players of Cold and Flu Drugs, Product and Application
 Table 25. Global Key Players of Cold and Flu Drugs, Date of Enter into This Industry
 Table 26. Mergers & Acquisitions, Expansion Plans
 Table 27. Global Cold and Flu Drugs Market Size by Type (2020-2025) & (US$ Million)
 Table 28. Global Cold and Flu Drugs Revenue Market Share by Type (2020-2025)
 Table 29. Global Cold and Flu Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 30. Global Cold and Flu Drugs Revenue Market Share by Type (2026-2031)
 Table 31. Global Cold and Flu Drugs Market Size by Application (2020-2025) & (US$ Million)
 Table 32. Global Cold and Flu Drugs Revenue Market Share by Application (2020-2025)
 Table 33. Global Cold and Flu Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 34. Global Cold and Flu Drugs Revenue Market Share by Application (2026-2031)
 Table 35. North America Cold and Flu Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. North America Cold and Flu Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 37. North America Cold and Flu Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Europe Cold and Flu Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Europe Cold and Flu Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 40. Europe Cold and Flu Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 41. Asia-Pacific Cold and Flu Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Asia-Pacific Cold and Flu Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 43. Asia-Pacific Cold and Flu Drugs Market Size by Region (2026-2031) & (US$ Million)
 Table 44. Latin America Cold and Flu Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Latin America Cold and Flu Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Latin America Cold and Flu Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Middle East & Africa Cold and Flu Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 48. Middle East & Africa Cold and Flu Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 49. Middle East & Africa Cold and Flu Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 50. Reckitt Benckiser Group Company Details
 Table 51. Reckitt Benckiser Group Business Overview
 Table 52. Reckitt Benckiser Group Cold and Flu Drugs Product
 Table 53. Reckitt Benckiser Group Revenue in Cold and Flu Drugs Business (2020-2025) & (US$ Million)
 Table 54. Reckitt Benckiser Group Recent Development
 Table 55. Johnson & Johnson Company Details
 Table 56. Johnson & Johnson Business Overview
 Table 57. Johnson & Johnson Cold and Flu Drugs Product
 Table 58. Johnson & Johnson Revenue in Cold and Flu Drugs Business (2020-2025) & (US$ Million)
 Table 59. Johnson & Johnson Recent Development
 Table 60. GlaxoSmithKline Company Details
 Table 61. GlaxoSmithKline Business Overview
 Table 62. GlaxoSmithKline Cold and Flu Drugs Product
 Table 63. GlaxoSmithKline Revenue in Cold and Flu Drugs Business (2020-2025) & (US$ Million)
 Table 64. GlaxoSmithKline Recent Development
 Table 65. Novartis Company Details
 Table 66. Novartis Business Overview
 Table 67. Novartis Cold and Flu Drugs Product
 Table 68. Novartis Revenue in Cold and Flu Drugs Business (2020-2025) & (US$ Million)
 Table 69. Novartis Recent Development
 Table 70. Bayer Company Details
 Table 71. Bayer Business Overview
 Table 72. Bayer Cold and Flu Drugs Product
 Table 73. Bayer Revenue in Cold and Flu Drugs Business (2020-2025) & (US$ Million)
 Table 74. Bayer Recent Development
 Table 75. AstraZeneca Company Details
 Table 76. AstraZeneca Business Overview
 Table 77. AstraZeneca Cold and Flu Drugs Product
 Table 78. AstraZeneca Revenue in Cold and Flu Drugs Business (2020-2025) & (US$ Million)
 Table 79. AstraZeneca Recent Development
 Table 80. Sun Pharmaceutical Industries Company Details
 Table 81. Sun Pharmaceutical Industries Business Overview
 Table 82. Sun Pharmaceutical Industries Cold and Flu Drugs Product
 Table 83. Sun Pharmaceutical Industries Revenue in Cold and Flu Drugs Business (2020-2025) & (US$ Million)
 Table 84. Sun Pharmaceutical Industries Recent Development
 Table 85. Pfizer Company Details
 Table 86. Pfizer Business Overview
 Table 87. Pfizer Cold and Flu Drugs Product
 Table 88. Pfizer Revenue in Cold and Flu Drugs Business (2020-2025) & (US$ Million)
 Table 89. Pfizer Recent Development
 Table 90. Prestige Brands Holdings Company Details
 Table 91. Prestige Brands Holdings Business Overview
 Table 92. Prestige Brands Holdings Cold and Flu Drugs Product
 Table 93. Prestige Brands Holdings Revenue in Cold and Flu Drugs Business (2020-2025) & (US$ Million)
 Table 94. Prestige Brands Holdings Recent Development
 Table 95. Procter & Gamble Company Details
 Table 96. Procter & Gamble Business Overview
 Table 97. Procter & Gamble Cold and Flu Drugs Product
 Table 98. Procter & Gamble Revenue in Cold and Flu Drugs Business (2020-2025) & (US$ Million)
 Table 99. Procter & Gamble Recent Development
 Table 100. Research Programs/Design for This Report
 Table 101. Key Data Information from Secondary Sources
 Table 102. Key Data Information from Primary Sources
 Table 103. Authors List of This Report


List of Figures
 Figure 1. Cold and Flu Drugs Picture
 Figure 2. Global Cold and Flu Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cold and Flu Drugs Market Share by Type: 2024 VS 2031
 Figure 4. Antihistamines Features
 Figure 5. Expectorants Features
 Figure 6. Bronchodilators Features
 Figure 7. Decongestants Features
 Figure 8. Antibiotics Features
 Figure 9. Others Features
 Figure 10. Global Cold and Flu Drugs Market Size by Application (2020-2031) & (US$ Million)
 Figure 11. Global Cold and Flu Drugs Market Share by Application: 2024 VS 2031
 Figure 12. OTC Case Studies
 Figure 13. Rx Case Studies
 Figure 14. Cold and Flu Drugs Report Years Considered
 Figure 15. Global Cold and Flu Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Cold and Flu Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Cold and Flu Drugs Market Share by Region: 2024 VS 2031
 Figure 18. Global Cold and Flu Drugs Market Share by Players in 2024
 Figure 19. Global Top Cold and Flu Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cold and Flu Drugs as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Cold and Flu Drugs Revenue in 2024
 Figure 21. North America Cold and Flu Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Cold and Flu Drugs Market Share by Country (2020-2031)
 Figure 23. United States Cold and Flu Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Cold and Flu Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Cold and Flu Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Cold and Flu Drugs Market Share by Country (2020-2031)
 Figure 27. Germany Cold and Flu Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Cold and Flu Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Cold and Flu Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Cold and Flu Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Cold and Flu Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Cold and Flu Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Cold and Flu Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Cold and Flu Drugs Market Share by Region (2020-2031)
 Figure 35. China Cold and Flu Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Cold and Flu Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Cold and Flu Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Cold and Flu Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Cold and Flu Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Cold and Flu Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Cold and Flu Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Cold and Flu Drugs Market Share by Country (2020-2031)
 Figure 43. Mexico Cold and Flu Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Cold and Flu Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Cold and Flu Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Cold and Flu Drugs Market Share by Country (2020-2031)
 Figure 47. Turkey Cold and Flu Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Cold and Flu Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Cold and Flu Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Reckitt Benckiser Group Revenue Growth Rate in Cold and Flu Drugs Business (2020-2025)
 Figure 51. Johnson & Johnson Revenue Growth Rate in Cold and Flu Drugs Business (2020-2025)
 Figure 52. GlaxoSmithKline Revenue Growth Rate in Cold and Flu Drugs Business (2020-2025)
 Figure 53. Novartis Revenue Growth Rate in Cold and Flu Drugs Business (2020-2025)
 Figure 54. Bayer Revenue Growth Rate in Cold and Flu Drugs Business (2020-2025)
 Figure 55. AstraZeneca Revenue Growth Rate in Cold and Flu Drugs Business (2020-2025)
 Figure 56. Sun Pharmaceutical Industries Revenue Growth Rate in Cold and Flu Drugs Business (2020-2025)
 Figure 57. Pfizer Revenue Growth Rate in Cold and Flu Drugs Business (2020-2025)
 Figure 58. Prestige Brands Holdings Revenue Growth Rate in Cold and Flu Drugs Business (2020-2025)
 Figure 59. Procter & Gamble Revenue Growth Rate in Cold and Flu Drugs Business (2020-2025)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Cold Treatment Drug Market Insights Forecast to 2030
Global Cough and Cold Remedie Market Insights Forecast to 2030
Global Cough Syrup Market Insights Forecast to 2030
Global Cough and Cold Medicine Market Insights Forecast to 2030
Global Influenza Therapeutics Market Insights Forecast to 2030
Cold Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Influenza Flu Antiviral Drugs Market Insights Forecast to 2030
Global OTC Cold and Cough Medicines Market Research Report 2024
Global Cold and Allergy Remedie Market Insights Forecast to 2030
Global Natural Cold Cough and Sore Throat Remedies Market Insights Forecast to 2030
Global Infectious Disease Drugs Market Insights Forecast to 2030
Global Cough Cold and Allergy Remedies Market Insights Forecast to 2030
Global Cough and Allergy Remedie Market Insights Forecast to 2030
Global Children Cough Medicine Market Insights Forecast to 2030
Global Antidepressants Drugs Market Insights Forecast to 2030
Global Chemotherapy Drug Market Insights Forecast to 2030
Global Natural Medicine Market Insights Forecast to 2030
Global Insomnia Treatment Drugs Market Insights Forecast to 2030
Global OTC Cough and Cold and Allergy Medicine Market Insights Forecast to 2028
Global Cold and Flu Supplement Market Research Report 2024

RELATED REPORTS

Global Multi-use Capsule-based Dry Powder Inhaler Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10O16568
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ruxolitinib Phosphate Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3G16891
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global NaSSAs Antidepressants Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4B16895
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Medication for Facial Features Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4D16704
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions